Medicine Information

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers


Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as "new and improved" doesn't necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they didn't manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of "What does this drug do?"

Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

Current World News

Report urges more sleep for medical residents
Los Angeles Times, CA - 30 minutes ago
Doctors in training should work no longer than 16 hours in a row without a five-hour nap to reduce risk to patients, according to the Institute of Medicine. ...
Medical Residents Must Sleep After 16 Hours, Experts Urge Washington Post
Expert Panel Seeks Changes in Training of Medical Residents New York Times
AASM responds to the Institute of Medicine's report on fatigue and ... EurekAlert (press release)
USA Today - Boston Globe
all 240 news articles


First Graduates of FSU College of Medicine Now Practicing Physicians
WCTV, FL - 12 hours ago
Fourteen members of the first class of students to graduate from The Florida State University College of Medicine recently completed the journey to becoming ...


Telegraph.co.uk

Strong medicine
Financial Times, UK - 20 hours ago
The European Commission is right to criticise drugmakers’ practice of extending their monopolies on high cost medicines by keeping out low-cost generic ...
Drug firms 'block' cheap medicine BBC News
EU report: Drug makers block market entry of competing medicines Xinhua
EU says drug industry delay tactics cost us €3bn Times Online
Out-Law.com - United Press International
all 338 news articles


Dr. Bill Hopper named MediCall Medical Director
MarketWatch - 12 hours ago
Dr. Hopper's more than three decades of clinical experience has included medical management, emergency medicine, solo rural family medicine, medical groups, ...
Med school dean at UND to step down In-Forum
Protein Attributed to Membrane Repair Identified - Mechanism May ... Newswise (press release)
USA Today Examines No-Cost Prescription Drug Samples Kaiser network.org
all 12 news articles


New York Times

The Six Habits of Highly Respectful Physicians
New York Times, United States - 2 hours ago
But as I noted last May in an article in The New England Journal of Medicine, medical schools may be underemphasizing a much simpler virtue: good manners. ...


A&M College of Medicine Cadaver Memorial Service
KBTX, TX - 13 hours ago
The Texas A&M Health Science Center College of Medicine will host its annual Cadaver Memorial Service on Wednesday, December 3 at 4:15 pm at the Reynolds ...


Incorporating Patient Preferences in Evidence-Based Medicine
Journal of American Medical Association (subscription), IL - 11 hours ago
However, their contention that the focus of guidelines on evidence-based medicine (EBM) is responsible for a delay in making values and preferences ...
Incorporating Patient Preferences in Evidence-Based Medicine—Reply Journal of American Medical Association (subscription)
all 2 news articles


Insurance commissioner to investigate ‘concierge’ medicine ...
IFAwebnews.com, MD - 10 hours ago
By Bob Graham Maryland Insurance Commissioner Ralph S. Tyler plans to investigate whether the growing use of “concierge” medicine practices trigger ...


San Francisco Chronicle

China Medicine Corporation Awarded GSP Certification
Pharmaceutical Online (press release), PA - 23 hours ago
In conjunction with China Medicine's success in obtaining the GSP certification, the Company will also be considered by the Guangdong FDA to include ...
Morning-after Pill More Accessible After FDA Decision The FDA ... Softpedia
Health Ranger Offers Thirty-One Predictions for 2009 - Health ... Natural News.com
all 197 news articles


MEDICINE CABINET: Options for treating inflamed salivary glands
Newsday, NY - 23 hours ago
I've been diagnosed with inflamed salivary glands. I've lived with this condition for almost five years. I have had some glands removed and have been tested ...

Medicine - Google News

home | site map
© 2006